{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:45:34Z","timestamp":1741189534130,"version":"3.38.0"},"reference-count":55,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.nephro.2010.12.010","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T11:40:52Z","timestamp":1297338052000},"page":"99-104","source":"Crossref","is-referenced-by-count":1,"title":["Calcimim\u00e9tiques\u00a0: physiologie, r\u00e9sultats d\u2019\u00e9tudes cliniques et perspectives"],"prefix":"10.1684","volume":"7","author":[{"given":"Pablo Urena","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2010.12.010_bib0005","first-page":"151","article-title":"Parathyroid gland, calcium receptor and calcimimetics","volume":"23","author":"Urena","year":"2002","journal-title":"Nephrologie"},{"key":"10.1016\/j.nephro.2010.12.010_bib0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.nephro.2010.12.010_bib0280","first-page":"1573","article-title":"Effects of potential calcium sensing receptor inducers on promoting chemosensitivity of human colon carcinoma cells","volume":"36","author":"Wang","year":"2010","journal-title":"Int J Oncol"},{"issue":"Suppl. 3","key":"10.1016\/j.nephro.2010.12.010_bib0020","first-page":"S25","volume":"14","author":"Brown","year":"2003","journal-title":"Is the calcium receptor a molecular target for the actions of strontium on bone? Osteoporos Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2008.10.043","article-title":"The calcimimetic R-568\u00a0retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein\u00a0E deficient (apoE-\/-) mice","volume":"205","author":"Ivanovski","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nephro.2010.12.010_bib0030","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.12.010_bib0035","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nephro.2010.12.010_bib0040","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1046\/j.1523-1755.1999.00386.x","article-title":"Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate","volume":"55","author":"Brown","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0045","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/jc.81.4.1598","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nephro.2010.12.010_bib0050","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1093\/ndt\/gfn338","article-title":"Simultaneous changes in the calcium-sensing receptor and the vitamin\u00a0D receptor under the influence of calcium and calcitriol","volume":"23","author":"Carrillo-Lopez","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0055","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1093\/ndt\/13.suppl_1.40","article-title":"Regulation of the parathyroid hormone gene by calcium, phosphate and 1,25-dihydroxyvitamin\u00a0D","volume":"13","author":"Silver","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0060","doi-asserted-by":"crossref","first-page":"F605","DOI":"10.1152\/ajprenal.90272.2008","article-title":"Direct upregulation of parathyroid calcium-sensing receptor and vitamin\u00a0D receptor by calcimimetics in uremic rats","volume":"296","author":"Mendoza","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0065","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1681\/ASN.2007121320","article-title":"Cinacalcet reduces the set point of the PTH-calcium curve","volume":"19","author":"Valle","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.1996.283","article-title":"1,25-dihydroxyvitamin\u00a0D3\u00a0and 22-oxacalcitriol prevent the decrease in vitamin\u00a0D receptor content in the parathyroid glands of uremic rats","volume":"50","author":"Denda","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0075","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ki.1991.315","article-title":"Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0080","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","article-title":"Calcimimetics with potent and selective activity on the parathyroid calcium receptor","volume":"95","author":"Nemeth","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nephro.2010.12.010_bib0085","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.V115903","article-title":"Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats","volume":"11","author":"Chin","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/ENDO:10:2:97","article-title":"The calcimimetic NPS R-568\u00a0decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism","volume":"10","author":"Fox","year":"1999","journal-title":"Endocrine"},{"key":"10.1016\/j.nephro.2010.12.010_bib0095","doi-asserted-by":"crossref","first-page":"F795","DOI":"10.1152\/ajprenal.90625.2008","article-title":"Regulation of PTH mRNA stability by the calcimimetic R568\u00a0and the phosphorus binder lanthanum carbonate in CKD","volume":"296","author":"Nechama","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0100","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1172\/JCI119851","article-title":"The calcimimetic compound NPS R-568\u00a0suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor","volume":"100","author":"Wada","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nephro.2010.12.010_bib0105","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","article-title":"NPS R-568\u00a0halts or reverses osteitis fibrosa in uremic rats","volume":"53","author":"Wada","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1523-1755.2000.00837.x","article-title":"Calcimimetic NPS R-568\u00a0prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism","volume":"57","author":"Wada","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0115","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type\u00a0II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nephro.2010.12.010_bib0120","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.ajkd.2004.08.029","article-title":"Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200mg once daily","volume":"44","author":"Harris","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.12.010_bib0125","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent AMG\u00a0073\u00a0lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","article-title":"The calcimimetic AMG\u00a0073\u00a0as a potential treatment for secondary hyperparathyroidism of end-stage renal disease","volume":"14","author":"Quarles","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1542-4758.2008.00244.x","article-title":"Marked improvement in bone metabolism parameters after increasing the dialysate calcium concentration from 2.5\u00a0to 3\u00a0mEq\/L in non hypercalcemic hemodialysis patients","volume":"12","author":"Molina Vila","year":"2008","journal-title":"Hemodial Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0140","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1093\/ndt\/gfp365","article-title":"Calcium balance in haemodialysis \u2013 do not lower the dialysate calcium concentration too much (con part)","volume":"24","author":"Drueke","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0145","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/j.1523-1755.2005.310_1.x","article-title":"High dialysate calcium may improve the efficacy of calcimimetic treatment in hemodialysis patients with severe secondary hyperparathyroidism","volume":"67","author":"Touam","year":"2005","journal-title":"Kidney Int"},{"issue":"Suppl. 5","key":"10.1016\/j.nephro.2010.12.010_bib0150","doi-asserted-by":"crossref","first-page":"V9","DOI":"10.1093\/ndt\/gfh1050","article-title":"Achieving therapeutic targets in the treatment of secondary hyperparathyroidism","volume":"19","author":"Cunningham","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1523-1755.2003.00720.x","article-title":"The calcimimetic AMG\u00a0073\u00a0reduces parathyroid hormone and calcium\u00d7phosphorus in secondary hyperparathyroidism","volume":"63","author":"Lindberg","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0160","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.12.010_bib0165","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2215\/CJN.06141108","article-title":"Simultaneous control of PTH and CaxP Is sustained over 3\u00a0years of treatment with cinacalcet HCl","volume":"4","author":"Sprague","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0170","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0175","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2215\/CJN.05241008","article-title":"Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004\u00a0through 2006","volume":"4","author":"St Peter","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0180","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/ndt\/gfp144","article-title":"Cinacalcet and achievement of the NKF\/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice \u2013 the ECHO observational study","volume":"24","author":"Urena","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0185","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.03790808","article-title":"Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients","volume":"4","author":"Belozeroff","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP69269","article-title":"An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism","volume":"69","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0285","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin\u00a0D on FGF23\u00a0levels in ESRD","volume":"5","author":"Wetmore","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0205","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1093\/ndt\/gfm312","article-title":"Calcimimetic increases osteoprotegerin and decreases fetuin-A levels in dialysis patients","volume":"22","author":"Messa","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0210","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.ajkd.2006.01.015","article-title":"Meta-analysis of biochemical and patient-level effects of calcimimetic therapy","volume":"47","author":"Strippoli","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.12.010_bib0215","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1093\/ndt\/gfn191","article-title":"Calcium-mediated parathyroid hormone release changes in patients treated with the calcimimetic agent cinacalcet","volume":"23","author":"de Francisco","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0220","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0225","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ndt\/gfn654","article-title":"Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism","volume":"24","author":"Meola","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0230","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ndt\/gfn579","article-title":"Regression of parathyroid gland swelling by treatment with cinacalcet","volume":"24","author":"Terawaki","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0235","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/MNM.0b013e3283305df6","article-title":"Dual-phase 99mTc-MIBI scintigraphy to assess calcimimetic effect in patients on haemodialysis with secondary hyperparathyroidism","volume":"30","author":"Fuster","year":"2009","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nephro.2010.12.010_bib0240","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/ndt\/gfp578","article-title":"Restoration of reversed whole PTH\/intact PTH ratio and reduction in parathyroid gland vascularity during cinacalcet therapy for severe hyperparathyroidism in a uraemic patient","volume":"25","author":"Komaba","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0245","first-page":"572A","article-title":"The effects of 1-year treatment with the calcimimetic AMG-073\u00a0on bone health in ESRD patients with secondary hyperparathyroidism (SHPT)","volume":"13","author":"Quarles","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0250","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfh829","article-title":"Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism","volume":"20","author":"Lien","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.010_bib0255","unstructured":"Raggi P, Chertow GM, Torres PU, Csiky B, et al. The Advance study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin\u00a0D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. First published online: December 8, 2010."},{"key":"10.1016\/j.nephro.2010.12.010_bib0260","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0265","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of Cinacalcet therapy to lower cardiovascular events (EVOLVE): rationale and design overview","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.010_bib0270","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.010_bib0275","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.ajkd.2008.07.043","article-title":"Progression of calcification in the calcium acetate renagel evaluation-2 (Care-2) Study","volume":"52","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725511000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725511000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2010.12.010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:01:14Z","timestamp":1741186874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725511000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1769725511000046"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2010.12.010","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}